Volume 143, Issue 4, Pages e4 (October 2012)

Slides:



Advertisements
Similar presentations
Volume 50, Issue 4, Pages (April 2009)
Advertisements

Volume 138, Issue 5, Pages e10 (May 2010)
Volume 122, Issue 5, Pages (May 2002)
Volume 144, Issue 5, Pages e10 (May 2013)
Volume 132, Issue 2, Pages (February 2007)
Volume 137, Issue 4, Pages (October 2009)
Volume 140, Issue 2, Pages e1 (February 2011)
Volume 154, Issue 4, Pages e6 (March 2018)
Volume 141, Issue 4, Pages e6 (October 2011)
Volume 141, Issue 3, Pages e4 (September 2011)
Volume 134, Issue 5, Pages e1 (May 2008)
Volume 142, Issue 4, Pages (April 2012)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 140, Issue 2, Pages e1 (February 2011)
Volume 144, Issue 7, Pages e10 (June 2013)
Volume 137, Issue 3, Pages e7 (September 2009)
Volume 140, Issue 3, Pages e3 (March 2011)
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 134, Issue 5, Pages (May 2008)
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 145, Issue 5, Pages (November 2013)
Volume 141, Issue 5, Pages (November 2011)
Volume 140, Issue 3, Pages e10 (March 2011)
Volume 141, Issue 4, Pages e2 (October 2011)
Volume 133, Issue 4, Pages (October 2007)
miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation
Zinc Mesoporphyrin Induces Rapid Proteasomal Degradation of Hepatitis C Nonstructural 5A Protein in Human Hepatoma Cells  Weihong Hou, Qing Tian, Jianyu.
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 133, Issue 3, Pages (September 2007)
Volume 143, Issue 3, Pages (September 2012)
Volume 138, Issue 4, Pages (April 2010)
Volume 143, Issue 6, Pages e4 (December 2012)
Volume 22, Issue 5, Pages (May 2014)
Volume 142, Issue 7, Pages e3 (June 2012)
Volume 141, Issue 2, Pages e1 (August 2011)
Volume 153, Issue 5, Pages e2 (November 2017)
Volume 154, Issue 6, Pages (May 2018)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 132, Issue 2, Pages (February 2007)
Volume 42, Issue 3, Pages (March 2015)
Volume 139, Issue 3, Pages e3 (September 2010)
Volume 11, Issue 6, Pages (June 2012)
Volume 135, Issue 6, Pages (December 2008)
Volume 31, Issue 1, Pages (July 2009)
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 138, Issue 2, Pages e4 (February 2010)
Volume 140, Issue 4, Pages (April 2011)
Volume 144, Issue 2, Pages (February 2013)
Volume 143, Issue 1, Pages e3 (July 2012)
Volume 135, Issue 3, Pages e3 (September 2008)
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins  Harel Dahari, Stephen M. Feinstone,
Volume 139, Issue 1, Pages e4 (July 2010)
Volume 127, Issue 3, Pages (September 2004)
Volume 132, Issue 5, Pages (May 2007)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 133, Issue 4, Pages (October 2007)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 137, Issue 4, Pages e6 (October 2009)
A View to Natural Killer Cells in Hepatitis C
Volume 140, Issue 7, Pages e2 (June 2011)
Volume 147, Issue 4, Pages e8 (October 2014)
Volume 117, Issue 4, Pages (October 1999)
Volume 123, Issue 4, Pages (October 2002)
Volume 43, Issue 5, Pages (November 2015)
Volume 29, Issue 4, Pages (October 2008)
Volume 142, Issue 7, Pages e6 (June 2012)
Endogenous Control of Immunity against Infection: Tenascin-C Regulates TLR4- Mediated Inflammation via MicroRNA-155  Anna M. Piccinini, Kim S. Midwood 
Volume 138, Issue 2, Pages e4 (February 2010)
Presentation transcript:

Volume 143, Issue 4, Pages 1048-1060.e4 (October 2012) Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated With Early Control of Hepatitis C Virus  Su–Hyung Park, Eui–Cheol Shin, Stefania Capone, Laura Caggiari, Valli De Re, Alfredo Nicosia, Antonella Folgori, Barbara Rehermann  Gastroenterology  Volume 143, Issue 4, Pages 1048-1060.e4 (October 2012) DOI: 10.1053/j.gastro.2012.06.005 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Late and transient appearance of HCV-specific CD8 T cells in mock-vaccinated control chimpanzees during HCV challenge. Serum HCV RNA titers (filled diamonds) and ALT levels (open squares) have previously been reported12 and are shown for reference purposes. HCV RNA titers became undetectable by quantitative and qualitative polymerase chain reaction for 3 chimpanzees (A–C) but remained just above the detection limit for chimp 97A015 (asterisk in D). Error bars represent the SEM from 3 experiments. The HCV protein and first amino acid position of the epitope presented by the tetramer are indicated in each panel. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Early expansion and long-term persistence of HCV-specific CD8 T cells during HCV challenge of vaccinees. Serum HCV RNA titers (filled diamonds) and ALT levels (open squares) of 4 vaccinated chimpanzees (A–D) have previously been reported12 and are shown for reference purposes. Error bars represent the SEM from 3 experiments. The HCV protein and first amino acid position of the epitope presented by the tetramer are indicated in each panel. Ad3X, 3 consecutive vaccinations with a replication-defective recombinant adenovirus encoding HCV NS3-5; DNA3X, 3 consecutive boosts with recombinant DNA plasmid encoding HCV NS3-5. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Vaccine-induced HCV-specific CD8 T cells express more CD127 and less PD-1 than infection-induced HCV-specific T cells. (A) Frequency of CD127+ cells and CD127 MFI and (C) frequency of PD-1+ cells and PD-1 MFI in the HCV-specific tetramer-positive CD8 T-cell population. Graphs show mean ± SEM for each group. Serial-measures ANOVA is used to compare these parameters for vaccine-induced HCV-specific CD8 T cells from the vaccinated chimpanzees (filled circles) and infection-induced HCV-specific CD8 T cells from the control chimpanzees (open circles) in the acute phase of hepatitis (up to week 20) and the entire time course. Infection-induced NS31359-specific T cells of the vaccinated chimpanzee 95A014 are shown (half-filled, half-open circles). (B) Increased CD127 and (D) decreased PD-1 expression are limited to HCV-specific T cells of the vaccinated chimpanzees and not seen on bulk CD8 T cells. Vaccinated and control chimpanzees are compared at the time with (B) the highest percentage of CD127+ HCV-specific T cells and (D) the highest MFI of PD-1–positive HCV-specific T cells. The horizontal line indicates the arithmetic mean. NS31359-specific T cells of vaccinee 95A014 were excluded from the analysis, because these cells were induced by infection rather than the vaccine. See Supplementary Figure 2 for FACS dot plots. (E) Correlation between PD-1 expression and viremia. Filled symbols, vaccines; open symbols, mock-vaccinated control chimpanzees. R, correlation coefficient. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Vaccine-induced, but not infection-induced, CD8 T cells secrete multiple cytokines. (A) The percentage of IFN-γ– and/or TNF-α–secreting cells in the population of tetramer-positive CD8 T cells is higher in vaccinated chimpanzees than in control chimpanzees at all studied time points. (B) The percentage of multifunctional IFN-γ/TNF-α double-positive cells in the population of cytokine-secreting HCV-specific CD8 T cells is higher in vaccinated chimpanzees than in control chimpanzees. The selected time points represent the time of HCV challenge (week 0), peak viral load (weeks 9–11), the time just after HCV clearance (weeks 15–19), and long-term follow-up (week 27). The sum of all IFN-γ– and/or TNF-α–secreting cells is 100%. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 Strong correlation between cytokine secretion and expression of (A) CD127 but not (B) PD-1 early after HCV challenge. Vaccine-induced tetramer-positive T cells are indicated by filled symbols, and infection-induced T cells of the control chimpanzees are indicated by open symbols. The infection-induced NS31359-specific tetramer-positive T cells in the vaccinated chimpanzee 95A014 (indicated by half filled, half open circles) did not display the CD127 phenotype and superior cytokine production of the vaccine-induced tetramer-positive T cells but instead resembled the infection-induced T cells of the control chimpanzees. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 Intrahepatic PD-1, PD-L1, and 2,5-OAS-1 mRNA expression levels throughout the course of HCV challenge. (A) Intrahepatic PD-1, PD-L1, and 2,5-OAS-1 mRNA levels normalized to endogenous references (β-actin, GAPDH, and β7) and expressed as fold increase over preinfection levels. (B) Peak PD-1 mRNA levels, normalized to CD8β mRNA levels, differed between control mock-vaccinated chimpanzees and vaccinees. (C and D) Linear regression analysis (C) between peak intrahepatic PD-L1 and 2,5-OAS-1 mRNA levels and (D) between peak HCV RNA titers and peak intrahepatic PD-1, PD-L1 and 2,5-OAS-1 mRNA levels, respectively. Open circles, mock-vaccinated control chimpanzees; filled circles, vaccinees. R, correlation coefficient. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 1 Representative FACS dot plots demonstrating the percentage of HCV tetramer+CD8 T cells of control chimpanzees (A) and vaccines (B). Dot plots are presented with a logarithmic scale. The numbers in the upper right indicate the percentage of tetramer+ cells in the CD8 T cell population. Ad3X, 3 consecutive vaccinations with a replication-defective recombinant adenovirus encoding the non-structural NS3-5B region of the HCV genotype 1b BK strain; DNA3X, 3 consecutive boosts with recombinant DNA plasmids encoding the same HCV antigens. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 2 Peak CD127 and PD-1 expression in the tetramer+ T cell population during the first 20 weeks of HCV infection. Study time point (week after HCV-challenge) and infection status (HCV+, viremia; HCV-, no viremia) are indicated above each graph. Quadrant numbers indicate the percentage and the MFI for the respective marker. NS3-1359-specific T cells of vaccinee 95A014 are marked by an asterisk. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 3 Functional analysis of tetramer+ T cells. (A–D) IFN- γ and TNF-α secretion of tetramer+ and bulk CD8+ T cells was determined after in vitro stimulation of PBMC with cognate antigen at (A) the time point of HCV challenge (week 0), and at (B) week 9, and (C) weeks 15–19, (D) week 27. Tetramer+ T cells were not detectable in the control chimpanzees at week 0 and week 9. (E) Cytokine production of infection-induced tetramer+ T cells in the vaccinated chimpanzee 95A014. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 3 Functional analysis of tetramer+ T cells. (A–D) IFN- γ and TNF-α secretion of tetramer+ and bulk CD8+ T cells was determined after in vitro stimulation of PBMC with cognate antigen at (A) the time point of HCV challenge (week 0), and at (B) week 9, and (C) weeks 15–19, (D) week 27. Tetramer+ T cells were not detectable in the control chimpanzees at week 0 and week 9. (E) Cytokine production of infection-induced tetramer+ T cells in the vaccinated chimpanzee 95A014. Gastroenterology 2012 143, 1048-1060.e4DOI: (10.1053/j.gastro.2012.06.005) Copyright © 2012 AGA Institute Terms and Conditions